Importance of the hydrophobic sulfoxide substituent on nontoxic analogs of sparsomycin.

AUTOR(ES)

Ash, R J

RESUMO

Nontoxic analogs of sparsomycin were competitive inhibitors of puromycin in the peptidyl transferase assay with Escherichia coli polysomes. The sensitivity of HeLa cells in vitro to the analogs was used as a preliminary index of cellular toxicity. In vitro killing of HeLa cells by this class of compounds correlated well with in vivo 50% lethal doses. The data indicate that modification of the hydrophobic sulfoxide substituent on sparsomycin decreases the toxicity of the molecule for mammalian cells by several hundredfold. Such modifications have less of an effect on the inhibitory activity of the compounds for peptidyl transferase. The differential effects of an analog active against bacterial but not mammalian cells was due to a decreased uptake of the compound by HeLa cells.

Documentos Relacionados

• Purification and preliminary characterization of (E)-3-(2,4-dioxo-6-methyl-5-pyrimidinyl)acrylic acid synthase, an enzyme involved in biosynthesis of the antitumor agent sparsomycin.
• Effect of sparsomycin on protein synthesis in the mouse liver.
• Endotoxic induction of prostaglandin release from macrophages by nontoxic lipid A analogs synthesized chemically.
• Conformational analysis of neuropeptide Y-[18-36] analogs in hydrophobic environments.
• Substituent influence on the diastereoselectivity of the alkylation of cyclic chiral imines